New research looks at novel ways to combat drug resistance

University of Southampton biological scientists are leading a major research project aimed at making drugs more effective.

They are investigating a group of proteins called 'multidrug transporters', which remove unwanted and toxic material from cells. Normally these proteins protect cells from toxins, but multidrug transporters also prevent anticancer drugs from killing , particularly since the amount of these proteins is increased in cancer cells when they encounter such drugs. Related proteins also remove antibiotics from bacteria and remove herbicides from the plant cells of weeds leading to herbicide .

All cells are surrounded by a membrane made of molecules called lipids, which forms a barrier that prevents the movement of many important into and out of the cell. Embedded in this barrier are proteins that provide the cell with the ability to take in nutrients and remove waste and .

Dr Malcolm East, a Reader in Biochemistry, who is leading the research with Dr Howard Barton, a Reader in Biochemistry and Molecular Biology, says: "Besides ejecting waste material, cells also remove drugs, which make them less effective as treatments. We believe that a particular group of lipids, called anionic lipids, within cell membranes play a role in controlling the of certain membrane proteins. We want to know how lipids interact with proteins and how that affects their ability to transport drugs.

"Understanding these mechanisms could suggest ways of improving the effectiveness of antibiotics, anti-malarial drugs and cancer treatments and boost the action of herbicides and pesticides."

Anionic lipids in the membrane change in amount and distribution when cells respond to changes in their environment. By labelling different proteins and lipids, the scientists can determine which lipids have a closer relationship with the multidrug transporter and how it affects the drug transporting ability of the protein.

Dr Barton adds: "These studies will tell us how signals are transmitted to by changes in membrane lipid composition and distribution.. In addition a greater understanding of how multidrug transporters are controlled by lipids, may suggest ways in which these proteins can be controlled by the use of novel drugs that would also interact with these multidrug transporters. This could help to tackle treatment failures caused by the serious problems of antibiotic resistance in bacteria and resistance to seen with repeated rounds of chemotherapy. A similar approach could be taken to provide strategies for reducing the resistance seen with a whole range of important molecules, including pesticides, herbicides and anti-malarials."

Dr East and Dr Barton have won £287,000 from the Biotechnology and Biological Sciences Research Council (BBSRC) for the three-year project.

add to favorites email to friend print save as pdf

Related Stories

From shape-shifting to therapy

Mar 12, 2013

(Medical Xpress)—The latest research into the intricate processes that let substances into and out of cells will help to lay the foundations for the next generation of therapies for major diseases.

The future of drug development

Sep 03, 2010

John Engen, associate professor of chemistry and chemical biology at the Northeastern University, is at the forefront of research that will advance drug discovery and development by making it easier to analyze ...

Recommended for you

Better living through mitochondrial derived vesicles

18 hours ago

(Medical Xpress)—As principal transformers of bacteria, organelles, synapses, and cells, vesicles might be said to be the stuff of life. One need look no further than the rapid rise to prominence of The ...

Zebrafish help to unravel Alzheimer's disease

20 hours ago

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain. A new study by scientists at ...

Engineering new bone growth

22 hours ago

MIT chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or defects, this coated scaffold ...

User comments